Table 2 Cost-effectiveness results
From: An economic evaluation of intensive hypertension control in CKD patients: a cost-effectiveness study
Intervention | Cost (US$) | Incremental Cost (US$) | Effectiveness (QALY) | Incremental Effectiveness (QALY) | Incremental cost effectiveness ratio (US$) | Cost/effectiveness (US$) | Category of dominance |
|---|---|---|---|---|---|---|---|
Standard | 136,298.1 | - | 11.37 | - | - | 11,992.6 | undominated |
Intensive | 140,572.4 | 4,274.3 | 11.60 | 0.24 | 18,125.7 | 12,117.2 | undominated |